nach oben

Osteoporosis International

Erschienen in:

01.05.2009 | Original Article

Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method

verfasst von: K. Imai, I. Ohnishi, T. Matsumoto, S. Yamamoto, K. Nakamura

Erschienen in: Osteoporosis International | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Summary

A QCT-based nonlinear FEM was used to assess vertebral strength and mechanical parameters in postmenopausal women. It had higher discriminatory power for vertebral fracture than aBMD and vBMD. Alendronate effects were detected at 3 months, and marked bone density increases were noted in juxta-cortical areas compared to inner trabecular areas.

Introduction

QCT-based finite element method (QCT/FEM) can predict vertebral compressive strength ex vivo. This study aimed to assess vertebral fracture risk and alendronate effects on osteoporosis in vivo using QCT/FEM.

Methods

Vertebral strength in 104 postmenopausal women was analyzed, and the discriminatory power for vertebral fracture was assessed cross-sectionally. Alendronate effects were also prospectively assessed in 33 patients with postmenopausal osteoporosis who were treated with alendronate for 1 year.

Results

On the age and body weight adjusted logistic regression, vertebral strength had stronger discriminatory power for vertebral fracture (OR per SD change: 6.71) than areal BMD and volumetric BMD. The optimal point for the vertebral fracture threshold was 1.95 kN with 75.9% sensitivity and 78.7% specificity. At 3 months, vertebral strength significantly increased by 10.2% from baseline. The minimum principal strain distribution showed that the area of high fracture risk decreased. At 1 year, the density of the inner cancellous bone increased by 8.3%, while the density of the juxta-cortical area increased by 13.6%.

Conclusions

QCT/FEM had higher discriminatory power for vertebral fracture than BMD and detected alendronate effects at 3 months. Alendronate altered density distributions, thereby decreasing the area with a high fracture risk, resulting in increased vertebral strength.

NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef

Edmondston SJ, Singer KP, Day RE et al (1994) In-vitro relationships between vertebral body density, size and compressive strength in the elderly thoracolumbar spine. Clin Biomech 9:180–186CrossRef

Cheng XG, Nicholson PH, Boonen S et al (1997) Prediction of vertebral strength in vitro by spinal bone densitometry and calcaneal ultrasound. J Bone Miner Res 12:1721–1728PubMedCrossRef

Eriksson SA, Isberg BO, Lindgren JU (1989) Prediction of vertebral strength by dual photon absorptiometry and quantitative computed tomography. Calcif Tissue Int 44:243–250PubMedCrossRef

Myers BS, Arbogast KB, Lobaugh B et al (1994) Improved assessment of lumbar vertebral body strength using supine lateral dual-energy X-ray absorptiometry. J Bone Miner Res 9:687–693PubMedCrossRef

Bjarnason K, Hassager C, Svendsen OL et al (1996) Anteroposterior and lateral spinal DXA for the assessment of vertebral body strength: comparison with hip and forearm measurement. Osteoporos Int 6:37–42PubMedCrossRef

Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMed

Cody DD, Gross GJ, Hou FJ et al (1999) Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech 32:1013–1020PubMedCrossRef

Keyak JH, Rossi SA, Jones KA et al (1998) Prediction of femoral fracture load using automated finite element modeling. J Biomech 31:125–133PubMedCrossRef

10.

Keyak JH, Rossi SA, Jones KA et al (2001) Prediction of fracture location in the proximal femur using finite element models. Med Eng Phys 23:657–664PubMedCrossRef

11.

Keyak JH (2001) Improved prediction of proximal femoral fracture load using nonlinear finite element models. Med Eng Phys 23:165–173PubMedCrossRef

12.

Bessho M, Ohnishi I, Matsuyama J et al (2007) Prediction of strength and strain of the proximal femur by a CT-based finite element method. J Biomech 40:1745–1753PubMedCrossRef

13.

Faulkner KG, Cann CE, Hasegawa BH (1991) Effect of bone distribution on vertebral strength: assessment with patient-specific nonlinear finite element analysis. Radiology 179:669–674PubMed

14.

Silva MJ, Keaveny TM, Hayes WC (1998) Computed tomography-based finite element analysis predicts failure loads and fracture patterns for vertebral sections. J Orthop Res 16:300–308PubMedCrossRef

15.

Martin H, Werner J, Andresen R et al (1998) Noninvasive assessment of stiffness and failure load of human vertebrae from CT-data. Biomed Tech 43:82–88CrossRef

16.

Buckley JM, Loo K, Motherway J (2007) Comparison of quantitative computed tomography-based measures in predicting vertebral strength. Bone 40:767–774PubMedCrossRef

17.

Crawford RP, Cann CE, Keaveny TM (2003) Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone 33:744–750PubMedCrossRef

18.

Liebschner MA, Kopperdahl DL, Rosenberg D et al (2003) Finite element modeling of the human thoracolumbar spine. Spine 28:559–565PubMedCrossRef

19.

Imai K, Ohnishi I, Bessho M et al (2006) Nonlinear finite element model predicts vertebral bone strength and fracture site. Spine 31:1789–1794PubMedCrossRef

20.

Lian KC, Lang TF, Keyak JH et al (2005) Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women. Osteoporos Int 16:642–650PubMedCrossRef

21.

Keaveny TM, Donley DW, Hoffmann PF et al (2007) Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 22:149–157PubMedCrossRef

22.

Melton LJ III, Riggs BL, Keaveny TM et al (2007) Structural determinants of vertebral fracture risk. J Bone Miner Res 22:1885–1892PubMedCrossRef

23.

Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337PubMedCrossRef

24.

Imai K, Ohnishi I, Yamamoto S et al (2008) In vivo assessment of lumbar vertebral strength in elderly women using computed tomography-based nonlinear finite element model. Spine 33:27–32PubMedCrossRef

25.

World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129

26.

Devogelaer JP, Broll H, Correa-Rotter R et al (1996) Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18:141–150PubMedCrossRef

27.

Tucci JR, Tonino RP, Emkey RD et al (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488–501PubMedCrossRef

28.

Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541PubMedCrossRef

29.

Liberman UA, Weiss SR, Broll J et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443PubMedCrossRef

30.

Cummings SR, Black DM, Thompson DE et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082PubMedCrossRef

31.

Pols HA, Felsenberg D, Hanley DA et al (1999) Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int 9:461–468PubMedCrossRef

32.

Ensrud KE, Black DM, Palermo L et al (1997) Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 157:2617–2624PubMedCrossRef

33.

McClung MR, San Martin J, Miller PD et al (2005) Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165:1762–1768PubMedCrossRef

34.

Black DM, Greenspan SL, Ensrud KE et al (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207–1215PubMedCrossRef

35.

Dougherty G, Newman D (1999) Measurement of thickness and density of thin structures by computed tomography: a simulation study. Med Phys 26:1341–1348PubMedCrossRef

36.

Prevrhal S, Engelke K, Kalender WA (1999) Accuracy limits for the determination of cortical width and density: the influence of object size and CT imaging parameters. Phys Med Biol 44:751–764PubMedCrossRef

37.

Boivin GY, Chavassieux PM, Santora AC et al (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687–694PubMedCrossRef

38.

Roschger P, Rinnerthaler S, Yates J et al (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185–191PubMedCrossRef

39.

Cummings SR, Karpf DB, Harris F et al (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281–289PubMedCrossRef

40.

McNamara LM, Prendergast PJ (2007) Bone remodelling algorithms incorporating both strain and microdamage stimuli. J Biomech 40:1381–1391PubMedCrossRef

41.

Balena R, Toolan BC, Shea M et al (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577–2586PubMedCrossRef

42.

Fischer KJ, Vikoren TH, Ney S et al (2006) Mechanical evaluation of bone samples following alendronate therapy in healthy male dogs. J Biomed Mater Res B Appl Biomater 76:143–148PubMed

Titel: Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method
verfasst von: K. Imai
I. Ohnishi
T. Matsumoto
S. Yamamoto
K. Nakamura
Publikationsdatum: 01.05.2009
Verlag: Springer-Verlag
Erschienen in: Osteoporosis International / Ausgabe 5/2009
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-008-0750-8

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Summary

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2009

Sex-specific association of serum vitamin D levels with physical function in older adults

The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study

Olympic fencers: adaptations in cortical and trabecular bone determined by quantitative computed tomography

Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study

Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo